Table 1 Baseline patient characteristics

Age^a (year)

54.29 ± 11.87

54.16 ± 13.42

Gender^b

 Male

25 (80.6)

49 (86)

 Female

6 (19.4)

8 (14)

Classification of PVTT^b

 Vp3

10 (32.3)

24 (42.1)

 Vp4

21 (67.7)

33 (57.9)

ECOG performance^b

 0

17 (54.8)

34 (59.6)

 1

9 (29.1)

20 (35.1)

 2

5(16.1)

3(5.3)

Cause of liver disease^b

 HBV

31 (100)

57 (100)

 Other

0 (0)

0 (0)

Liver Cirrhosis^b

 Absent

8 (25.8)

13 (22.8)

 Present

23 (74.2)

44 (77.2)

Distant metastasis^b

 Lung

2 (6.5)

2 (3.5)

 Others

0 (0)

0 (0)

Ascites^b

 Absent

26 (83.9)

46 (80.7)

 Mild

1(3.2)

3(5.3)

 Moderate

3(9.7)

7(12.3)

 Massive

1(3.2)

1(1.7)

Child-Pugh score^b

 A

25 (80.6)

33 (57.9)

 B

6 (19.4)

24 (42.1)

Tumor description^b

 1

6 (19.4)

11(19.3)

 2

4 (12.9)

9(15.8)

 ≥ 3

21 (67.7)

37 (64.9)

Size of largest tumor, median (cm)

7.00

8.5

 Time^a (seconds)

8.65 ± 1.74

–

 Pressure^a (MPa)

243.55 ± 92.86

–

 Speed^a (ml/s)

1.63 ± 0.43

–

 Total procedure Time^a (hour)

1.92 ± 0.62

0.62 ± 0.18

 Alcohol^a (ml)

7.77 ± 3.95

–

 Epirubicin^a (mg)

50.00

50.00

 Number of sessions

2.42 ± 1.71

1.89 ± 0.98

Laboratory Tests

 Total bilirubin level^a (μmol/L)

22.15 ± 12.63

20.91 ± 9.19

 Albumin level^a (g/L)

39.22 ± 8.12

41.68 ± 5.91

 α-Fetoprotein^b (ng/mL)

 < 200

10 (23.8)

22 (38.6)

 200–1000

4 (29)

11 (19.3)

 > 1000

17 (42.9)

24 (42.1)

 Prothrombin time^a (seconds)

12.86 ± 1.66

13.01 ± 1.17

 Thrombin time^a (seconds)

19.41 ± 2.35

19.71 ± 1.23